Active Ingredient: LITHIUM CARBONATE
Proprietary Name: LITHIUM CARBONATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N018558
Product Number: 001
Approval Date: Jan 29, 1982
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information